Department of Basic and Translational Oncology and Hematology

2024

The emerging role of Artificial Intelligence in proton therapy: a review

Isaksson, L. J., Mastroleo, F., Vincini, M. G., Marvaso, G., Zaffaroni, M., Gola, M., Mazzola, G. C., Bergamaschi, L., Gaito, S., Alongi, F., Doyen, J., Fossati, P., Haustermans, K., Høyer, M., Langendijk, J. A., Matute, R., Orlandi, E., Schwarz, M., Troost, E. G. C. & Vondracek, V. & 6 others, La Torre, D., Curigliano, G., Petralia, G., Orecchia, R., Alterio, D. & Jereczek-Fossa, B. A., 02 Sept 2024, (E-pub ahead of print) In: Critical Reviews in Oncology/Hematology. 204, p. 104485 104485.

Research output: Journal article (peer-reviewed) › Review article

2023

State-of-the-art and potential of experimental microdosimetry in ion-beam therapy

Magrin, G., Palmans, H., Stock, M. & Georg, D., May 2023, In: Radiotherapy and Oncology. 182, 109586.

Research output: Journal article (peer-reviewed) › Review article

13 Citations (Scopus)

The Role of Carbon Ion Therapy in the Changing Oncology Landscape-A Narrative Review of the Literature and the Decade of Carbon Ion Experience at the Italian National Center for Oncological Hadrontherapy

Orlandi, E., Barcellini, A., Vischioni, B., Fiore, M. R., Vitolo, V., Iannalfi, A., Bonora, M., Chalaszczyk, A., Ingargiola, R., Riva, G., Ronchi, S., Valvo, F., Fossati, P., Ciocca, M., Mirandola, A., Molinelli, S., Pella, A., Baroni, G., Pullia, M. G. & Facoetti, A. & 4 others, Orecchia, R., Licitra, L., Vago, G. & Rossi, S., 20 Oct 2023, In: Cancers. 15, 20, 5068.

Research output: Journal article (peer-reviewed) › Review article

Open Access

10 Citations (Scopus)

2022

On the continuous (R)evolution of antibody-based and CAR T cell therapies in multiple myeloma: an early 2022 glance into the future

Sunder-Plassmann, V., Aksoy, O., Lind, J., Pecherstorfer, M., Vallet, S. & Podar, K., 2022, In: Expert Opinion on Pharmacotherapy. 23, 12, p. 1425-1444 20 p.

Research output: Journal article (peer-reviewed) › Review article

1 Citation (Scopus)

2021

Management of Adverse Events and Supportive Therapy in Relapsed/Refractory Multiple Myeloma

Pozzi, S., Bari, A., Pecherstorfer, M. & Vallet, S., 01 Oct 2021, In: Cancers. 13, 19, 4978.

Research output: Journal article (peer-reviewed) › Review article

Open Access

8 Citations (Scopus)

Relapsed/Refractory Multiple Myeloma in 2020/2021 and Beyond

Podar, K. & Leleu, X., 01 Oct 2021, In: Cancers. 13, 20, 5154.

Research output: Journal article (peer-reviewed) › Review article

Open Access

38 Citations (Scopus)

The Role of AP-1 Transcription Factors in Plasma Cell Biology and Multiple Myeloma Pathophysiology

Fan, F. & Podar, K., 02 May 2021, In: Cancers. 13, 10, 2326.

Research output: Journal article (peer-reviewed) › Review article

Open Access

25 Citations (Scopus)

2019

Emerging protein kinase inhibitors for the treatment of multiple myeloma

Lind, J., Czernilofsky, F., Vallet, S. & Podar, K., 03 Jul 2019, In: Expert Opinion on Emerging Drugs. 24, 3, p. 133-152 20 p.

Research output: Journal article (peer-reviewed) › Review article

22 Citations (Scopus)

Targeting transcription factors in multiple myeloma: evolving therapeutic strategies

Li, S., Vallet, S., Sacco, A., Roccaro, A., Lentzsch, S. & Podar, K., 04 May 2019, In: Expert Opinion on Investigational Drugs. 28, 5, p. 445-462 18 p.

Research output: Journal article (peer-reviewed) › Review article